Market Research Logo

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

“The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.”
The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA sequencing industry.

“Pharmaceutical & biotechnology companies segment to witness the highest growth in the NGS-based RNA-sequencing market during the forecast period.”
Based on the end-user, the NGS-based RNA-sequencing industry is segmented into research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness highest growth rate during the forecast period mainly due to growing number of agreements and collaborations between NGS market players and pharmaceutical & biotechnology companies for the development of advanced products.

“Expression profiling analysis application to hold the largest share in the NGS-based RNA-sequencing market.”
Based on application, the NGS-based market is segmented into expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share mainly due to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases will propel the demand for expression profiling analysis to provide specific treatment options in the market during the forecast period.

“The Asia Pacific market is expected to witness the highest CAGR during the forecast period.”
The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.

Breakdown of supply-side primary interviews:
By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
By Designation: C-level: 47%, D-level: 33%, and Others: 20%
By Region: North America: 35%, Europe: 32%, APAC: 25%, Latin America: 6% and Middle East & Africa: 2%

The major players operating in the NGS-based RNA-sequencing market are Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market

Research Coverage
This report studies the NGS-based RNA-sequencing market based on product & service, technology, application, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa (and the respective countries in these regions).

Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis—market ranking analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the NGS-based RNA-sequencing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY USED FOR THE STUDY
    • MARKET STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET ESTIMATION METHODOLOGY
      • PRODUCT-BASED MARKET ESTIMATION
      • APPLICATION-BASED MARKET ESTIMATION
      • PRIMARY RESEARCH VALIDATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
    • RESEARCH LIMITATIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • NGS-BASED RNA-SEQUENCING: MARKET OVERVIEW
    • NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
    • NGS-BASED RNA-SEQUENCING MARKET SHARE, BY TECHNOLOGY, 2019 VS. 2024
    • NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
    • NGS-BASED RNA-SEQUENCING MARKET SHARE, BY END USER, 2019 VS. 2024
    • GEOGRAPHICAL SNAPSHOT OF THE NGS-BASED RNA-SEQUENCING MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
    • RNA SEQUENCING PLATFORMS & CONSUMABLES
      • INCREASING AVAILABILITY OF PLATFORMS AND GROWING CONSUMABLE USAGE HAVE ENSURED THE HIGH SHARE OF THIS SEGMENT
        • Table RNA SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
    • SAMPLE PREPARATION PRODUCTS
      • SAMPLE PREPARATION IS THE FIRST STEP OF AN NGS WORKFLOW
        • Table SAMPLE PREPARATION PRODUCTS MARKET, BY REGION, 2017–2024 (USD MILLION)
      • SAMPLE PREPARATION PRODUCTS, BY WORKFLOW
      • SAMPLE PREPARATION PRODUCTS, BY METHOD
    • RNA SEQUENCING SERVICES
      • LACK OF INFRASTRUCTURE AND EXPERTISE AMONG END USERS HAS DRIVEN DEMAND FOR SERVICES
        • Table RNA SEQUENCING SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
    • DATA ANALYSIS, STORAGE & MANAGEMENT
      • INTEGRATION OF CLOUD COMPUTING AND BIOINFORMATICS, AMONG OTHER ADVANCEMENTS, IS CONTRIBUTING TO MARKET GROWTH
        • Table DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY REGION, 2017–2024 (USD MILLION)
  • NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
    • SEQUENCING BY SYNTHESIS
      • SBS TECHNOLOGY ENABLES THE HIGHEST PRODUCTION OF BASE PAIRS IN A SHORT PERIOD OF TIME
        • Table SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2017–2024 (USD MILLION)
    • ION SEMICONDUCTOR SEQUENCING
      • ION SEMICONDUCTOR SEQUENCING PLATFORMS POSSESS HIGH-THROUGHPUT CAPABILITIES
        • Table ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION)
    • SINGLE-MOLECULE REAL-TIME SEQUENCING
      • SMRT SEQUENCING PRODUCES RESULTS IN A SHORT TIME AND AT LOWER COSTS
        • Table SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION)
    • NANOPORE SEQUENCING
      • NANOPORE SEQUENCING IS THE ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA-SEQUENCING CAPABILIT IES
        • Table NANOPORE SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION)
  • NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION
    • INTRODUCTION
      • Table NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
    • EXPRESSION PROFILING ANALYSIS
      • INCREASING NEED FOR IMPROVED PROGNOSIS OF PATIENTS TO PROPEL MARKET GROWTH
        • Table EXPRESSION PROFILING ANALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION)
    • SMALL RNA SEQUENCING
      • RISING NEED FOR ACCURATE DIAGNOSTIC ANALYSIS TO SUPPORT MARKET GROWTH
        • Table SMALL RNA SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION)
    • DE NOVO TRANSCRIPTOME ASSEMBLY
      • INCREASING CANCER CASES IS EXPECTED TO DRIVE THIS APPLICATION SEGMENT
        • Table DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY REGION, 2017–2024 (USD MILLION)
    • VARIANT CALLING & TRANSCRIPTOME EPIGENETICS
      • COMPLICATED RNA-SEQ DATA ANALYSIS MAY HAMPER THE GROWTH OF THIS SEGMENT
        • Table VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY REGION, 2017–2024 (USD MILLION)
  • NGS-BASED RNA-SEQUENCING MARKET, BY END USER
    • INTRODUCTION
      • Table NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2017–2024 (USD MILLION)
    • RESEARCH & ACADEMIA
      • INCREASING NUMBER OF COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND ACADEMIC & RESEARCH INSTITUTES TO PROPEL MARKET GROWTH
        • Table NGS-BASED RNA-SEQUENCING MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2017–2024 (USD MILLION)
    • HOSPITALS & CLINICS
      • INCREASING ADOPTION OF NGS SYSTEMS IN HOSPITALS & CLINICS TO DRIVE MARKET GROWTH
        • Table NGS-BASED RNA-SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017–2024 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • CONSOLIDATION BETWEEN BIOTECH & PHARMA COMPANIES AND NGS MARKET PLAYERS TO PROPEL MARKET GROWTH
        • Table NGS-BASED RNA-SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
    • OTHER END USERS
      • Table NGS-BASED RNA-SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2017–2024 (USD MILLION)
  • NGS-BASED RNA-SEQUENCING MARKET, BY REGION
    • INTRODUCTION
      • Table NGS-BASED RNA-SEQ MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
      • Table NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
      • Table NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
      • Table NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • Table NORTH AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017–2024 (USD MILLION)
      • US
        • Table US: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table US: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table US: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • CANADA
        • Table CANADA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table CANADA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table CANADA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
      • Table EUROPE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
      • Table EUROPE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
      • Table EUROPE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • Table EUROPE: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017–2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table GERMANY: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table GERMANY: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • UK
        • Table UK: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table UK: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table UK: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table FRANCE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table FRANCE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • ROE
        • Table ROE: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table ROE: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table ROE: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
      • Table ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
      • Table ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
      • Table ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • Table ASIA PACIFIC: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017–2024 (USD MILLION)
      • CHINA
        • Table CHINA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table CHINA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table CHINA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table JAPAN: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table JAPAN: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • INDIA
        • Table INDIA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table INDIA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table INDIA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • ROAPAC
        • Table ROAPAC: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table ROAPAC: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table ROAPAC: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
      • Table LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
      • Table LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
      • Table LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • Table LATIN AMERICA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017–2024 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table BRAZIL: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table BRAZIL: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • MEXICO
        • Table MEXICO: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table MEXICO: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table MEXICO: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
      • ROLA
        • Table ROLA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table ROLA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table ROLA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • LACK OF INFRASTRUCTURE HAS STIFLED MARKET GROWTH IN THE MEA
        • Table MEA: NGS-BASED RNA-SEQ MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
        • Table MEA: NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
        • Table MEA: NGS-BASED RNA-SEQ MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
        • Table MEA: NGS-BASED RNA-SEQ MARKET, BY END USER, 2017–2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • COMPETITIVE LEADERSHIP MAPPING
      • TERMINOLOGY/NOMENCLATURE
    • COMPETITIVE SCENARIO (2015-2019)
      • Table NEW PRODUCT LAUNCHES
      • Table ACQUISITIONS
      • Table PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • NGS-BASED RNA-SEQUENCING MARKET RANKING, BY TOP THREE MARKET PLAYERS (2018)
  • COMPANY PROFILES
    • AGILENT TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • BGI GROUP
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • EUROFINS SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • GENEWIZ (PART OF BROOKS AUTOMATION)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • HAMILTON COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ILLUMINA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
      • MNM VIEW
    • NUGEN TECHNOLOGIES (PART OF TECAN TRADING AG)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • OXFORD NANOPORE TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • PERKINELMER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • PSOMAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • QIAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • TAKARA BIO
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
      • MNM VIEW
    • ZYMO RESEARCH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016–2019)
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report